Business Context and Reporting Period
This Form 8-K Current Report was filed by Retractable Technologies, Inc. on September 25, 2009. The filing discloses a specific corporate governance event regarding the compensation of the Company's Chief Executive Officer.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or debt metrics. The only financial data disclosed relates to the valuation of a specific stock option grant:
- Option Grant Size: 3,000,000 shares of Common Stock.
- Exercise Price: $0.81 per share (100% of fair market value on grant date).
- Grant Date Fair Value: $1,762,500 (calculated using the Black-Scholes model).
- Market Value at Grant Date: $4,860,000 (based on a closing price of $1.62 per share).
Material Changes
The material change reported is the approval of a new stock option grant to Thomas J. Shaw, the Company's founder, President, and CEO. This grant was approved by shareholders at the Annual Meeting and was issued outside of the Company's 2008 Stock Option Plan, though it contains similar terms with a 10-year term instead of five.
Outlook, Risks, and Unusual Items
Compensatory Arrangement Details:
- Vesting Date: July 15, 2010.
- Termination Date: July 15, 2019.
- Termination Provisions:
- Death, Disability, or Termination (not for cause): Vested portion terminates 12 months after the event; non-vested portion terminates immediately.
- Termination for Cause: Option terminates immediately.
The filing does not contain forward-looking guidance, general risk factors, or discussion of contingencies beyond the specific terms of this option grant.
Investor Verification Checklist
- Verify the total number of outstanding shares to assess the dilution impact of the 3,000,000 share grant.
- Confirm the specific terms of the 2008 Stock Option Plan to compare against the unique 10-year term of this grant.
- Review the Company's most recent 10-K or 10-Q for current liquidity and debt positions, as this 8-K does not provide them.
- Monitor the vesting schedule to determine the timing of potential future dilution.